Further studies to determine whether the serum OPG and TRAIL levels of patients with diabetes could be indicators for the progression of diabetes or if the progression of diabetes could be controlled by regulating serum OPG and TRAIL levels are necessary. This evidence concerns the gene TNFRSF11B and diabetes mellitus.